Effects of Powered Hip Flexion Device in Persons With Multiple Sclerosis

Starting soon · Not applicable

Conditions studied: Multiple Sclerosis (MS) Relapsing Remitting

In brief

The purpose of this study is to assess the immediate effects of a commercially available non-FDA regulated powered hip flexion assist device (Hypershell X, Shenzhen, China) on walking ability in persons with MS. The main question it aims to answer is: Does a powered hip flexion device provide immediate improvements in walking ability over short distances for people with MS?

Key facts

Study ID

NCT07724093

Run by

University of Dayton

People needed

10

Starts

2026-07-15

Expected to finish

2028-05-01

Last updated by the study team

2026-07-23

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-80
• Diagnosis of relapsing remitting, primary progressive or secondary progressive MS
• Unilateral or bilateral hip flexion weakness (Manual muscle testing score of 3 or less)
• Ability to walk at least 30 meters without requiring rest and without physical support or assistance from another person.
• Waist circumference 26-48", Height 5 '- 6'2", Weight 100-230lbs

You may not qualify if…

• Prior regular use of a hip flexion orthosis within the past 6 months.
• Cognitive or communication deficits that would limit ability to participate safely.
• Significant pain or deformity of the lower extremities that could impact walking ability.
• Severe spasticity (Modified Ashworth Score of 3 or 4) of the hips or lower extremities that could impact walking ability.
• Any other neurological conditions that may affect gait.

Where it is running

• University of Dayton — Dayton, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.